2021
DOI: 10.1016/j.ijid.2020.12.075
|View full text |Cite
|
Sign up to set email alerts
|

Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

13
172
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 212 publications
(185 citation statements)
references
References 38 publications
(32 reference statements)
13
172
0
Order By: Relevance
“…In contrast, the mortality-minimizing strategies are relatively robust to variations in vaccine efficacy. Our modeling of mortality-minimizing strategies led to consistent recommendations to prioritize adults aged 50 years and older across efficacy values, in line with prior work [36]. This recommendation is robust because of the dramatic differences in case-fatality rates by age.…”
Section: Discussionsupporting
confidence: 76%
“…In contrast, the mortality-minimizing strategies are relatively robust to variations in vaccine efficacy. Our modeling of mortality-minimizing strategies led to consistent recommendations to prioritize adults aged 50 years and older across efficacy values, in line with prior work [36]. This recommendation is robust because of the dramatic differences in case-fatality rates by age.…”
Section: Discussionsupporting
confidence: 76%
“…Authors came to the conclusion that older age groups should be prioritized first. The prioritization of older age groups led to the greatest relative reduction in death regardless of vaccine efficacy [ 42 ].…”
Section: Discussionmentioning
confidence: 99%
“…The model we developed in this study is different from most models developed in many countries that prioritize vaccination for the elderly, such as simulated scenarios for India [ 2 ], United States, Germany, and South Korea [ 17 ]. Those models showed that prioritizing COVID-19 vaccine allocation for older populations (i.e., >60 years) resulted in the most significant relative reduction in deaths and could maximize years of remaining life expectancy.…”
Section: Discussionmentioning
confidence: 99%
“…The unprecedented pandemic caused by coronavirus disease 2019 (COVID-19) leads to a global race to find the most effective vaccine and deliver it most efficiently [ 1 , 2 ]. However, when the COVID-19 vaccination aims at achieving global herd immunity, an estimated 5.5 billion out of a total of 7.8 billion world population would demand 11 billion doses of COVID-19 vaccines [ 3 ].…”
Section: Introductionmentioning
confidence: 99%